Article Text

PDF
▼Tamiflu − the wrong message?

Statistics from Altmetric.com

Widespread use of ▼oseltamivir (Tamiflu) has been a key strategy in tackling the H1N1 ‘swine flu’ pandemic in the UK. Is the increasing disquiet about this policy justified?

In clinical trials on seasonal influenza, neuraminidase inhibitors (oseltamivir and ▼zanamivir) have reduced transmission of influenza A but provided only modest symptomatic improvement. Oseltamivir's use in the current H1N1 pandemic has had various objectives: to limit transmission; to …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.